As vaccine makers seek authorization for a fourth dose of their Covid vaccines in America, existing delays with vaccination and a lack of federal funding could slow the next booster rollout across the country, experts say.
“We’re way behind the eight-ball,” said Eric Topol, founder and director of the Scripps Research Translational Institute. The rollout of the first round of boosters, authorized in the US last fall, “just fell off the cliff”, with many Americans still not realizing they are eligible or that the booster is recommended.
